RU2013155770A - MEANS FOR CORRECTION OF DISTURBANCES IN PULMONARY TISSUE UNDER CYTOSTATIC EXPOSURE - Google Patents

MEANS FOR CORRECTION OF DISTURBANCES IN PULMONARY TISSUE UNDER CYTOSTATIC EXPOSURE Download PDF

Info

Publication number
RU2013155770A
RU2013155770A RU2013155770/15A RU2013155770A RU2013155770A RU 2013155770 A RU2013155770 A RU 2013155770A RU 2013155770/15 A RU2013155770/15 A RU 2013155770/15A RU 2013155770 A RU2013155770 A RU 2013155770A RU 2013155770 A RU2013155770 A RU 2013155770A
Authority
RU
Russia
Prior art keywords
disturbances
correction
tissue under
pulmonary tissue
exposure
Prior art date
Application number
RU2013155770/15A
Other languages
Russian (ru)
Other versions
RU2554776C1 (en
Inventor
Ольга Антоновна Лебедько
Борис Яковлевич Рыжавский
Ольга Викторовна Демидова
Владимир Кириллович Козлов
Original Assignee
Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" СО РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" СО РАМН filed Critical Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" СО РАМН
Priority to RU2013155770/15A priority Critical patent/RU2554776C1/en
Application granted granted Critical
Publication of RU2554776C1 publication Critical patent/RU2554776C1/en
Publication of RU2013155770A publication Critical patent/RU2013155770A/en

Links

Landscapes

  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Применение гистохрома в качестве средства, способного предотвращать фиброз легочной ткани, развивающийся при воздействии цитостатиками.The use of histochrome as a means that can prevent pulmonary fibrosis, which develops when exposed to cytostatics.

Claims (1)

Применение гистохрома в качестве средства, способного предотвращать фиброз легочной ткани, развивающийся при воздействии цитостатиками. The use of histochrome as a means that can prevent pulmonary fibrosis, which develops when exposed to cytostatics.
RU2013155770/15A 2013-12-16 2013-12-16 Agent for correcting pulmonary tissue disorders under cytostatic exposure RU2554776C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013155770/15A RU2554776C1 (en) 2013-12-16 2013-12-16 Agent for correcting pulmonary tissue disorders under cytostatic exposure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013155770/15A RU2554776C1 (en) 2013-12-16 2013-12-16 Agent for correcting pulmonary tissue disorders under cytostatic exposure

Publications (2)

Publication Number Publication Date
RU2554776C1 RU2554776C1 (en) 2015-06-27
RU2013155770A true RU2013155770A (en) 2015-06-27

Family

ID=53497023

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013155770/15A RU2554776C1 (en) 2013-12-16 2013-12-16 Agent for correcting pulmonary tissue disorders under cytostatic exposure

Country Status (1)

Country Link
RU (1) RU2554776C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2659682C1 (en) * 2017-08-21 2018-07-03 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Means based on biologically active compounds of marine hydrobionts with cancer protective action and increasing the therapeutic activity of antitumor antibiotics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618420D0 (en) * 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment
PT1100589E (en) * 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti USE OF PROPIONYL-L-CARNITINE AND ACETYL-L-CARNITINE IN THE PREPARATION OF MEDICINES WITH ANTICANCERIGENIC ACTIVITY
RU2134107C1 (en) * 1998-10-12 1999-08-10 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Preparation "gistokhrom" for treatment of eye retina and cornea inflammatory sicknesses
RU2193550C1 (en) * 2001-03-05 2002-11-27 Тихоокеанский институт биоорганической химии Дальневостоного отделения РАН Method of synthesis of 2,5,8-trihydroxy-6,7-dichloro-3-ethyl-1,4-naphthoquinone

Also Published As

Publication number Publication date
RU2554776C1 (en) 2015-06-27

Similar Documents

Publication Publication Date Title
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
BR112017009454A2 (en) active polycyclic derivatives with pesticide-active sulfur-containing substituents
BR112017015514A2 (en) active polycyclic derivatives with pesticide-active sulfur-containing substituents
BR112017014064A2 (en) active polycyclic derivatives with pesticide-active sulfur-containing substituents
UY34763A (en) INHIBITORS OF THE PLAQUETARY AGGREGATION
UY4277S (en) CAMERA
BR112017028600A2 (en) active polycyclic derivatives with pesticide-active sulfur-containing substituents
UY4281Q (en) PLAYER
UY4223Q (en) BANK
MX2015011837A (en) Co-crystals of pyrimethanil and selected dithiine tetracarboximide.
PH12015502146A1 (en) 4-amino-6-(4-substituted-phenyl)-picolinates and 6-amino-2-(4-substituted-phenyl)-pyrimidine-4-carboxylates and their use as herbicides
PH12017501071A1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
GB2531864B (en) Supporting RMA API over active message
SG10201900598TA (en) Factor viii formulation
IN2014DN11078A (en)
CR20170090A (en) TERAHYDROQUINOLINE DERIVATIVES AS BROMODOMINUM INHIBITORS
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
JP2015016294A5 (en)
FR3027522B1 (en) POROUS COMPOSITION CHARGED AS ACTIVE
MX2016003207A (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation.
UY4243Q (en) BANK
RU2013155770A (en) MEANS FOR CORRECTION OF DISTURBANCES IN PULMONARY TISSUE UNDER CYTOSTATIC EXPOSURE
BR112016028081A2 (en) NEW COMPOUNDS AS ANTITUBERCULAR AGENTS
UY34755A (en) AGENTS FOR THE CONTROL OF GLYCASPIS BRIMBLECOMBEI

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20171217